Although much has been written about the involvement of the pyroptosis process in AD, to date, studies linking pyroptosis to AD have primarily been conducted on cerebrospinal fluid (CSF) samples, where a significant increase in GSDMD levels has been reported, suggesting its potential as a biomarker for AD [88]. This evidence concerns the gene GSDMD and Alzheimer disease.